Risk of recurrent venous thromboembolism in patients with autoimmune diseases : data from the Registro Informatizado de Enfermedad TromboEmbólica (RIETE) registry

Jaime Borjas Howard, Pablo Ruiz-Sada, Karina de Leeuw, Luciano López-Jiménez, Carme Font, Pablo Javier Marchena, Olga Madridano, Philippe Debourdeau, Karina Meijer, Manuel Monreal

Research output: Contribution to journalArticleResearchpeer-review

8 Citations (Scopus)

Abstract

Autoimmune disease is a risk factor for first incident venous thromboembolism (VTE). However, data on the risk of recurrent VTE in people with autoimmune disease is sparse. We explored the risk of recurrent VTE using the RIETE registry, comparing people with autoimmune disease (n = 1305) to those without (n = 50608). Overall rates were 6.5 and 5.1 recurrent VTE/100 years for patients with autoimmune disease vs controls, respectively. After adjustment for sex and unprovoked/provoked VTE yielded an adjusted hazard ratio of 1.29 (95%CI 1.03-1.62). The analysis was limited by short median follow up time (161 days overall), precluding definitive conclusions on recurrent VTE risks.
Original languageEnglish
Pages (from-to)195-199
Number of pages5
JournalBritish Journal of Haematology
Volume194
DOIs
Publication statusPublished - 2021

Keywords

  • Autoimmune disease
  • Risk factors
  • Venous thrombosis

Fingerprint

Dive into the research topics of 'Risk of recurrent venous thromboembolism in patients with autoimmune diseases : data from the Registro Informatizado de Enfermedad TromboEmbólica (RIETE) registry'. Together they form a unique fingerprint.

Cite this